Hyperparathyroidism secondary to zoledronic acid infusion: case report.
Sayin
Meral
M
Yazici
Gozde
G
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000139:chemically induced*; D007093:Imidazoles / Q000009:adverse effects*; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid